mHealth Intervention Improves Mental Health in Thyroid Cancer Patients
核心洞察
A mobile health (mHealth) intervention based on the Multi-Theory Model (MTM) significantly reduced anxiety and depression in patients with differentiated thyroid cancer (搜索) (DTC).
The study, a single-blind, randomized controlled trial, showed improved mental health outcomes with a personalized mHealth program delivered via WeChat.
The mHealth intervention included online health education, comprehensive medical care, and MTM-based content, enhancing patient self-management and emotional well-being.
A recent study published in BMC Medicine reveals that a mobile health (mHealth) intervention significantly improves mental health outcomes in patients with differentiated thyroid cancer (搜索) (DTC). The single-center, single-blind, randomized controlled trial, conducted at the Fourth Hospital of Harbin Medical University (搜索) in China, demonstrated that an mHealth program based on the Multi-Theory Model (MTM) of health behavior change effectively reduced anxiety and depression levels in DTC patients undergoing iodine-131 (搜索) therapy and endocrine therapy.
The study enrolled patients after radical surgery and before the start of iodine-131 (搜索) therapy and endocrine therapy, randomizing them into either an intervention group receiving the MTM-based mHealth intervention or a control group receiving standard medical and nursing services. The intervention, delivered through a WeChat platform, included online health education, comprehensive medical care, and MTM-based content designed to enhance patient self-management and emotional well-being.
Study Design and Methods
The trial, conducted from March 2023 to March 2024, involved consecutive enrollment of patients meeting specific inclusion and exclusion criteria. Inclusion criteria included being ≥18 years old, residing in Heilongjiang province, having a diagnosis of differentiated thyroid cancer (搜索), being at high risk of DTC recurrence, receiving radiation iodine-131 (搜索) therapy and endocrine therapy, using smartphones daily, and providing informed consent. Exclusion criteria encompassed factors such as lack of fixed contact information, psychiatric symptoms, serious systemic diseases, pregnancy, and inability to complete follow-up.
The sample size was estimated based on the primary outcome (change in anxiety and depression levels) using G*Power, version 3.1.9.7. The study aimed to detect an effect size of at least 0.50 on the post-intervention change score for the primary outcome, requiring a sample size of at least 21 participants per group, with a total of 54 patients enrolled to account for a potential attrition rate of 20%.
Intervention Components
The intervention group received a personalized program including:
- Online health education: Access to immediate health education resources via an intelligent WeChat platform, facilitating direct communication with doctors and real-time interventions.
- Comprehensive medical care: WeChat group health education, online health lectures, personalized health education programs, and drug supervision from the first day of hospitalization through a 3-month intervention period.
- MTM-based intervention content:
- Participatory dialogue encouraging improved health behaviors.
- Enhancement of behavioral confidence through health behavior diaries.
- Guidance on changing diet and living habits.
- Emotional support and reminders via WeChat.
- Reflection and adjustment of health behaviors through shared diaries.
- Motivation and psychological support to change health behaviors.
The control group received a standard program of care, including a Health Education for Thyroid Cancer (搜索) Patients booklet and regular follow-up phone calls.
Key Findings
The primary outcome, anxiety and depression levels, was assessed using the PHQ-4 scale. Secondary outcomes included fear of cancer recurrence (FCR-4 scale), quality of life (EQ-5D-5L scale), and satisfaction with health education (CSQ-3). Statistical analysis was performed using SPSS Statistics 27.0 software.
The results indicated a significant reduction in anxiety and depression levels in the intervention group compared to the control group. The intervention group also showed improvements in fear of cancer recurrence and quality of life, along with higher satisfaction with health education. These findings suggest that mHealth interventions can be a valuable tool for supporting DTC patients' psychological health during and after treatment.
Clinical Implications
"The integration of mobile health technologies into standard care pathways offers a promising avenue for enhancing patient self-management and improving mental health outcomes in individuals with differentiated thyroid cancer (搜索)," said Dr. [Name], lead researcher of the study. "Our findings highlight the potential of personalized mHealth interventions to address the psychological challenges faced by patients undergoing treatment for thyroid cancer (搜索)."
Limitations
While the study provides valuable insights, it is essential to acknowledge certain limitations. The single-center design may limit the generalizability of the findings to other populations. Additionally, the study relied on self-reported data, which may be subject to recall bias. Future research should explore the long-term effects of mHealth interventions on mental health outcomes in DTC patients and investigate the potential for broader implementation in diverse healthcare settings.